Gene Therapy Situation Gets More Awkward With Another Death In Astellas XLMTM Study

Patient Received Lower Dose Of AT132 After Initial Hold Lifted

 
• By Alaric DeArment
  
genetic reasearch
Astellas reported a fourth patient death in its ASPIRO study of AT132 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Advanced Therapies